Piañar, Kathleen Marlet E.
HRN: 00013-27-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/01/2023
01/08/2023
IV
400mg
Q6hours
PCAP-B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes